If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker Offer to raise a maximum of £2.5m

27 Oct 2022 07:01

RNS Number : 2574E
Deepverge PLC
27 October 2022
 

DeepVerge PLC

 

("DeepVerge" or "Company")

 

Broker Offer to raise a maximum of £2.5m

 

· DeepVerge (AIM: DVRG) announces a Broker Offer through Turner Pope Investments (TPI) Limited. ("TPI")

· The Issue Price of the Broker Offer is 2 pence per New Ordinary Share.

· Every 4 (four) Broker Offer shares issued will have 1 (one) Placing Warrant attached, exercisable at 3 pence per Placing Warrant, for a period of 12 months from Admission of the Broker Offer shares.

· The Broker Offer has an initial expected value of £1.0 million, but may be extended to £2.5 million with the express agreement of the Company.

· Existing Shareholders or other interested parties who are qualified investors who wish to register their interest in participating in the Broker Offer should click on the following TPI platform link: DeepVerge - TPI Broker Offer (URL: https://forms.office.com/r/nptcgkst65)

· All bids communicated to TPI under the Broker Offer are subject to review and acceptance by the Company and TPI and priority will be given to Existing Shareholders in the event of oversubscription.

· The Broker Offer remains open until 4:30 p.m. on Friday, 28 October 2022.

· All Broker Offer shares will be issued subject to shareholders' approval at a General Meeting expected to take place on 14 November 2022.

 

Turner Pope Broker Offer

DeepVerge, the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, is pleased to announce that it wishes to provide Existing Shareholders and other investors who did not participate in the oversubscribed Fundraising announced today the opportunity to invest in the Company. Accordingly, under the Placing Agreement, TPI has been granted an option in the form of a Broker Offer under which TPI will, as agent for the Company, invite subscriptions for additional new Ordinary Shares with a value expected to be around £1.0 million at the Issue Price but which may be increased up to £2.5 million subject to agreement between TPI and the Company. Accordingly, the maximum number of New Ordinary Shares to be issued under the Broker Offer at the Issue Price is 125,000,000. The maximum number of Placing Warrants to be issued under the Broker Offer is 31,250,000.

 

The Broker Offer opens immediately and will close at 4.30 p.m. on Friday, 28 October 2022.

 

As far as is practical, participation in the Broker Offer will be prioritised for shareholders (direct or indirect) on the register at the close of business on 26 October 2022 ("Existing Shareholders"). If the expected maximum subscription under the Broker Offer is taken up, it will raise an additional £2.5 million, before expenses.

 

To subscribe for Broker Offer Shares, Existing Shareholders or other interested parties who are qualified investors who wish to register their interest in participating in the Broker Offer should click on the following link: DeepVerge - TPI Broker Offer (URL: https://forms.office.com/r/nptcgkst65)

A further announcement will be made following the end of the period during which the Broker Offer is open. If the Broker Offer is not fully subscribed by 4.30 p.m. on 28 October 2022, orders from eligible investors will be satisfied in full, and the balance of the Broker Offer shall lapse.

 

General Meeting

Completion of the Broker Offer is conditional on the relevant Resolutions being passed at the General Meeting, which is expected to take place on 14 November 2002. Admission of the Broker Offer Shares is expected on or around 16 November 2002. Further detail on the General Meeting and key dates for Admission of New Ordinary Shares are contained in the RNS detailing the Fundraising, also issued today, and will be available in the Circular to be published to the Company's website www.deepverge.com.

 

For further information, please contact:

 

DeepVerge plc

Ross Andrews, Chairman

+44 (0) 1904 40 4036

 

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELEFMEESEFS
Date   Source Headline
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202211:06 amRNSSecond Price Monitoring Extn
30th Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSBlue Carbon Resilience project
5th Aug 20227:00 amRNSTrading Update
1st Aug 20227:00 amRNSModern Water secures £2.1m projects
20th Jul 20221:42 pmRNSResult of AGM
20th Jul 20227:00 amRNSDeepVerge to explore options for Labskin Division
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:36 pmRNSPrice Monitoring Extension
18th Jul 20227:01 amRNSModern Water monitoring systems deal worth £1.4m
4th Jul 20227:00 amRNSSkin Trust Club - update
30th Jun 20227:00 amRNSModern Water Q2 orders exceed £3m, RPT
27th Jun 202211:50 amRNSNotice of AGM
23rd Jun 20227:12 amRNSFinal Results
13th Jun 20227:00 amRNSNotice of Final Results and Annual Report
1st Jun 20221:36 pmRNSSkin Trust Club wins Best New Disrupter Brand
30th May 20227:00 amRNSTesting Services Framework Ag with Abingdon Health
26th Apr 20227:00 amRNSDeepVerge presents at Global Group Investor Summit
19th Apr 20227:00 amRNSUpdate; Manuf'g Service Agreement with Microsaic
19th Apr 20227:00 amRNSHolding(s) in Company
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
28th Mar 20227:00 amRNS1st UK Deployments of Microtox®PD in Wastewater
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
17th Mar 202210:59 amRNSDirector Dealing
17th Mar 20227:00 amRNSAcquisition; Loan Facility for global expansion
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
11th Mar 20227:00 amRNSDeepVerge Q1 production orders up 39% to £5m
21st Feb 20227:00 amRNS82% of Skin Trust Club members purchase via App
19th Jan 20227:00 amRNSMicrotoxPD detects 3 COVID variants of concern
17th Jan 202211:05 amRNSSecond Price Monitoring Extn
17th Jan 202211:00 amRNSPrice Monitoring Extension
11th Jan 20227:00 amRNSTrading Update
6th Jan 20227:00 amRNSMicrotox CTM installed ahead of Winter Olympics
13th Dec 20217:00 amRNSAmends to Agreement with Microsaic Systems; RPT
10th Dec 20219:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSCompact Microtox® PD launch scheduled for Q1 2022
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSRelated Party Transaction
11th Nov 20217:00 amRNSU.S. launch of Skin Trust Club at Beauty Connect
4th Nov 20218:00 amRNSPDMR Dealing
4th Nov 20217:00 amRNSGrant supports DeepVerge Centre of Excellence
3rd Nov 20217:00 amRNSConfirmation of Post-Offer Intention Statements
28th Oct 20217:00 amRNSMicrotox® PD installations as part of nat'l trial
21st Oct 20219:05 amRNSSecond Price Monitoring Extn
21st Oct 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.